Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: knowledge (207), skill (247), practice (614), understanding (571), familiarity (9), know-how (1000), occurrence (176)

Radioactive iodine treatment for thyroid cancer - patient information

Description: This factsheet explains what radioactive iodine (RAI) treatment for thyroid cancer is and what the treatment involves, so you know what
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Radioactive-iodine-treatment-for-thyroid-cancer-3871-PIL.pdf

Cytoreductive surgery for gynaecological cancer - patient information

Description: This factsheet explains what cytoreductive surgery is, what the procedure involves and what the possible risks are.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Cytoreductive-surgery-for-gynaecological-cancer-3842-PIL.pdf

Your hepatitis C treatment - Zepatier® - patient information

Description: This factsheet explains how hepatitis C is treated with a medication called Zepatier®.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Your-hepatitis-C-treatment-Zepatier®-1595-PIL.pdf

Maviret for hepatitis C - patient information

Description: Maviret® is a combination tablet that contains two drugs (Glecaprevir 100mg and Pibrentasvir 40mg).It is used to treat Hepatitis C
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Maviret-for-hepatitis-C-1769-PIL.pdf

Your hepatitis C treatment (Epclusa with/without Ribavirin) - patient information

Description: You are starting a course of Epclusa® with/without ribavirin to treat your hepatitis C infection. These medications are taken in
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Your-hepatitis-C-treatment-Epclusa-withwithout-Ribavirin-1621-PIL.pdf

Hepatitis C - Harvoni® with or without ribavirin - patient information

Description: Patient information factsheet Your hepatitis C treatment Harvoni® We have given you this factsheet because you h
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Hepatitis-C-Harvoni®-with-or-without-ribavirin-1258-PIL.pdf

Patient support hub - patient information

Description: Information about how the patient support hub services can help patients, families and carers
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Patient-support-hub-patient-information.pdf

Epcoritamab -Cycle 1 (Priming)

Description: Chemotherapy Protocol LYMPHOMA EPCORITAMAB -Cycle 1 - (28 Day -Priming) Regimen • Lymphoma-Epcoritamab – Cycle 1- (28 day -Pri
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-1-Priming-Ver1.pdf

Gastroscopy and endoscopic full thickness resection (EFTR) aftercare advice - patient information

Description: This factsheet explains what to expect after having a gastroscopy and endoscopic full thickness resection (EFTR).
Url: /Media/UHS-website-2019/Patientinformation/Endoscopy/Gastroscopy-and-endoscopic-full-thickness-resection-EFTR-aftercare-advice-3773-PIL.pdf

Institutional information_2024-25

Description: Institutional information – key facts for inclusion as appropriate Support statements must be personal to your application
Url: /Media/Southampton-Clinical-Research/Grants/Download/Institutional-information-2024-25.pdf

351 to 360 of 1000

Previous … 34 35 36 37 38 … Next